English
Home > Products > CAS NO 1012341-50-2

China CAS NO 1012341-50-2 Factory

We emphasize development and introduce new products into the market every year for CAS NO 1012341-50-2,1012341-50-2,Sacubitril intermediate,Sacubitril advance intermediate,(2R,4S)-5-((1,1'-Biphenyl)-4-yl), Living by quality, development by credit is our eternal pursuit, We firmly believe that after your visit we will become long-term partners.
CAS NO 1012341-50-2, We warmly welcome your patronage and will serve our clients both at home and abroad with items of superior quality and excellent service geared to the trend of further development as always. We believe you will benefit from our professionalism soon.

Related Products

Hot Products

  • 4-Chloro-N-methylpyridine-2-carboxamide Hydrochloride

    4-Chloro-N-methylpyridine-2-carboxamide Hydrochloride

    Product Name:4-Chloro-N-methylpyridine-2-carboxamide Hydrochloride
    Molecular Formula:C7H8Cl2N2O
    Molecular Weight:207.06
    CAS Registry Number:882167-77-3
  • Tetrabenzyl-voglibose

    Tetrabenzyl-voglibose

    Product Name:Tetrabenzyl-voglibose
    Molecular Formula:C38H45NO7
    Molecular Weight:627.77
    CAS Registry Number:115250-39-0
  • Pazopanib Hydrochloride

    Pazopanib Hydrochloride

    Product Name:Pazopanib Hydrochloride
    Molecular Formula:C21H24ClN7O2S
    Molecular Weight;473.98
    CAS Registry Number;635702-64-6
  • Borane-tetrahydrofuran complex

    Borane-tetrahydrofuran complex

    Product Name:Borane-tetrahydrofuran complex
    Molecular Formula:C4H11BO
    Molecular Weight:85.94
    CAS Registry Number:14044-65-6
  • Valeronitrile

    Valeronitrile

    Product Name:Valeronitrile
    Molecular Formula:C5H9N
    Molecular Weight:83.13
    CAS Registry Number:110-59-8
  • Acetone Semicarbazone

    Acetone Semicarbazone

    Product Name:Acetone Semicarbazone
    Molecular Formula:C4H9N3O
    Molecular Weight;115.13
    CAS Registry Number;110-20-3
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept